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Abstract
Dendritic cells (DCs) can be sub-divided into various subsets that play specialized roles in priming of adaptive immune
responses. Atherosclerosis is regarded as a chronic inflammatory disease of the vessel wall and DCs can be found in non-
inflamed and diseased arteries. We here performed a systematic analyses of DCs subsets during atherogenesis. Our data
indicate that distinct DC subsets can be localized in the vessel wall. In C57BL/6 and low density lipoprotein receptor-
deficient (Ldlr2/2) mice, CD11c+ MHCII+ DCs could be discriminated into CD1032 CD11b+F4/80+, CD11b+F4/802 and
CD11b2F4/802 DCs and CD103+ CD11b2F4/802 DCs. Except for CD1032 CD11b2 F4/802 DCs, these subsets expanded in
high fat diet-fed Ldlr2/2 mice. Signal-regulatory protein (Sirp)-a was detected on aortic macrophages, CD11b+ DCs, and
partially on CD1032 CD11b2 F4/802 but not on CD103+ DCs. Notably, in FMS-like tyrosine kinase 3-ligand-deficient (Flt3l2/
2) mice, a specific loss of CD103+ DCs but also CD1032 CD11b+ F4/802 DCs was evidenced. Aortic CD103+ and CD11b+ F4/
802 CD1032 DCs may thus belong to conventional rather than monocyte-derived DCs, given their dependence on Flt3L-
signalling. CD64, postulated to distinguish macrophages from DCs, could not be detected on DC subsets under
physiological conditions, but appeared in a fraction of CD1032 CD11b+ F4/802 and CD11b+ F4/80+ cells in atherosclerotic
Ldlr2/2mice. The emergence of CD64 expression in atherosclerosis may indicate that CD11b+ F4/802 DCs similar to CD11b+
F4/80+ DCs are at least in part derived from immigrated monocytes during atherosclerotic lesion formation. Our data
advance our knowledge about the presence of distinct DC subsets and their accumulation characteristics in atherosclerosis,
and may help to assist in future studies aiming at specific DC-based therapeutic strategies for the treatment of chronic
vascular inflammation.
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Introduction
Atherosclerosis is regarded as a chronic inflammatory disease of
the vessel wall [1]. Both macrophages and dendritic cells (DCs) can
be found in non-inflamed steady-state aortae and accumulate in
atherosclerotic lesions [1–6]. While DCs in the intima are
important in initial lesion formation by uptake of lipids and their
transformation into foam-cell-like cells [7], evidence is accumu-
lating that DCs are also critical in shaping adaptive immune
responses in atherosclerosis [1,5,6,8–10]. For instance, two DC
subsets with distinct functions in controlling regulatory T cell
homeoastasis and atherosclerotic lesion formation have been
revealed [1,10].
DCs can be sub-divided into various subsets that play
specialized roles in priming of adaptive immune responses [11].
However, although CD11c is commonly accepted as a pan-DC
marker, a clear identification of DCs is still limited by the lack of
unambiguous surface markers. In particular, the discrimination of
DCs from macrophages that share many markers and functions
remains challenging. Recently, aortic CD11c+MHCII+ DCs were
discriminated from CD11c2 MHCII+ macrophages by their low
phagocytic activity but strong immune stimulatory capacities, and
subdivided into CD11b+ F4/802, CD11b+ F4/80+ as well as
CD103+ subsets [10]. A systematic analysis of the presence of these
subsets and their accumulation in the course of lesion develop-
ment, however, has not yet been performed. Although it remains
to be determined if these cell subsets denominated as DCs and
macrophages represent true lineage subsets with distinct tran-
scriptional profiles, we here have adopted and refined the gating
strategy applied by Choi et al. and others and used the term DCs
when describing cells that express CD11c, and macrophages for
CD11c2 cells [6,10,12,13]; we have characterized and quantified
these cell subsets in C57BL/6 mice and atherosclerosis-prone mice
fed a high fat diet. Furthermore, we applied novel surface markers
to characterize these cell subsets during atherogenesis.
Materials and Methods
Mouse Models
CD11c-YFP reporter mice [14] were provided by M.
Nussenzweig (Rockefeller University, New York, New York,
USA). Apolipoprotein E-deficient (ApoE2/2) mice, low-density-
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lipoprotein-receptor-deficient (Ldlr2/2) mice and C57BL/6J mice
were obtained from the Jackson laboratory. Fms-related tyrosine
kinase 3 ligand (Flt3l2/2) mice were obtained from Taconic.
CD11c-YFP mice were crossed with ApoE2/2 mice. Female mice
were kept on a normal chow, or placed on a Western diet at 10–12
weeks of age for 6 or 12 weeks. Experiments were approved by
local authorities and complied with German animal protection
law. This study was carried out in accordance with the with
German animal protection law, approved by the Regierung von
Unterfranken, Wu¨rzburg, Germany (permit number 44/10).
Enzymatic Tissue Digestion and Flow Cytometry
For FACS analysis, aortae were flushed with PBS, excised,
carefully cleaned of all perivascular fat, and enzymatically digested
with liberase TL (Roche) for 30 minutes at 37uC in RPMI-1640
(LifeTechnologies). Fc receptors were blocked with CD16/CD32
(clone 93) antibodies (eBioscience) in PBS supplemented with 2%
mouse serum, 2% rabbit serum and 0.2% BSA prior to fluorescent
labeling. Staining for flow cytometric analysis included fluores-
cently labeled antibodies against CD11c (PE-Cy7/AlexaFluor 488,
clone N418), CD11b (AmCyan, clone M170), NK1.1 (PE-Cy7,
clone PK136), CD103 (PE/APC, clone 2E7), SIRPa (FITC, clone
P84), MHCII (eFlour450, clone M5/114.15.2), TCR-ß (PerCP-
Cy5.5, clone H57–597), F4/80 (APC/PacBlue, clone BM8),
PDCA (PE, clone eBio927) (eBioscience), CD19 (PerCP-Cy5.5,
clone 1D3), CD45 (APC-Cy7, clone 30-F11), MHCII (FITC,
clone 2G9) (BD Biosciences) and CD64 (APC, clone X54–5/7.1)
(BioLegends) in HBSS with 0.3 mM EDTA and 0.1% BSA.
Samples were analyzed using a FACSCanto II (BD Biosciences)
and FlowJo software (Tree Star).
Tissue Sections and Immunofluorescence Staining
The heart and aortae were perfused with 4% paraformaldehyde
(PFA) in PBS, embedded in Tissue Tek and processed in 5 mm
serial cryosections. Slides were mounted and nuclei were
counterstained with 49,6-Diamidino-2-phenylindole (DAPI, Vec-
tor laboratories). CD11c, F4/80 or CD68 staining was performed
on cryosections of the aortic root using biotin-labeled anti-CD11c
(Biolegend, clone N418), anti-CD68 (AbD Serotec, clone FA-11)
or anti-F4/80 (AbD Serotec, clone CI:A3-1) antibodies, detected
by Alexa-Fluor-555-Streptavidin (Molecular probes, Life Tech-
Figure 1. Localization of CD11c+ cells in the aortic root. (A) Aortic root sections of healthy and atherosclerotic apoE2/2CD11c-YFP mice (arrow
heads indicate CD11c+ cells, green). Nuclei are counterstained with DAPI (blue; scale bars, 50 mm).
doi:10.1371/journal.pone.0088452.g001
Figure 2. Identification of DC subsets in the aorta. Representative
FACS plots for identification of DC subsets in healthy, chow-fed Ldlr2/2
mice. After exclusion of TCRb+/CD19+ T and B cells, CD11c+ MHCII+ DCs
were further subdivided into CD103+ and CD1032 DCs. CD103+ DCs do
not express CD11b or F4/80 while CD1032 DCs were further subdivided
into CD11b+ F4/802, CD11b+ F4/80+ and CD11b2F4/802 DCs.
Macrophages were defined as CD11c2 MHCII+ CD11b+ F4/80+.
Representative contour plots from 6–9 mice per group are shown.
doi:10.1371/journal.pone.0088452.g002
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nologies), Alexa-Fluor-488 anti-rat IgG (Molecular probes, Life
Technologies) or biotinylated anti-rat antibody and Alexa-Fluor-
488-Streptavidin (Molecular probes, Life Technologies) respec-
tively. Images were recorded using a Leica DMLB fluorescence
microscope.
Statistics
Data represent mean6SEM and were analyzed by Student’s t-
test, ANOVA with Dunnett’s multiple comparison test (Prism 5.02
software, GraphPad), as appropriate. Differences where P,0.05
were considered to be statistically significant.
Results
Localization of CD11c+ Cells
Employing CD11c-YFP reporter mice, we used immunofluo-
rescence microscopy to localize CD11c+ cells in chow-fed healthy
as well as atherosclerotic apolipoprotein E-deficient (apoE)2/2
mice. CD11c+ cells could be detected in the intima, adventitia, and
within the valves in the aortic sinus in CD11c-YFP reporter mice,
in line with previous findings [4,6,15,16] (Figure 1). In
atherosclerotic CD11c-YFP apoE2/2 mice, numerous CD11c+
cells were detectable throughout the intima with a preference to
luminal plaque regions and the adventitia in the aortic sinus
(Figure 1); in the aorta, in particular in regions of the aortic arch
but also in thoracic and abdominal segments, and in the
innominate artery, we similarly observed CD11c+ cells within
plaques, whereas CD11c+ cells could only rarely be found in the
adventitia in these regions (Figure S1, and not shown).
Identification and Quantification of Distinct Aortic DC
Subsets
To phenotypically characterize and quantify DC subsets in
healthy and atherosclerotic arteries, enzymatically digested aortae
were subjected to multicolour flow cytometry. After exclusion of
CD19+ and TCRb+ B and T cells, respectively, DCs were
identified as CD11c+ MHCII+ cells within CD45+ leukocytes
[6,10,12,13] in C57BL/6 mice (not shown) and chow-fed low
density lipoprotein receptor-deficient (Ldlr2/2) mice (Figure 2).
Whereas the majority of aortic CD11c+ MHCII+ DCs showed no
staining for E-cadherin-ligand CD103, a small CD103+ DC
population could be confined. This subset displayed no expression
of CD11b or F4/80 (Figure 2), in line with previous data [10]. In
contrast, the CD1032 fraction of aortic DCs could further be
subdivided into a large population of CD11c+ CD11b+ F4/80+
DCs and a less abundant CD11c+ CD11b+ F4/802 subset, as
described previously [10], but also CD11c+ CD11b2 F4/802 cells
(Figure 2). Within the subset of CD11c+ CD11b2 F4/802 cells
we were able to identify sporadic CD11clo CD11b2 PDCA+ cells,
in line with the presence of few plasmacytoid DCs (pDCs) [17,18].
Due to their low numbers (125642 pDCs per aorta, amounting to
approximately 1.6% of CD11c+ MHCII+ DCs), we refrained from
further studying this DC subset in subsequent analyses in this
study. All DC subsets were negative for expression of the NK/
NKT cell marker NK1.1 (data not shown). In line with previous
gating strategies [10], CD11c2 MHCII+ cells that co-stained for
CD11b and F4/80 were denominated as macrophages (Figure 2).
To assess the kinetics of the accumulation of these cell
subpopulations during atherogenesis, we compared aortic digests
of C57BL/6 mice with Ldlr2/2 mice fed a normal chow and
Ldlr2/2 mice fed a high fat diet (HFD) for 6 and 12 weeks. In line
with the presence of these cell types in healthy mice [3,4,6,16],
numerous macrophages and also DCs could already be identified
in C57BL/6 mice (Figure 3). Ldlr2/2 mice on normal chow
displayed a non-significant trend towards elevated numbers of
DCs when compared to C57BL/6 mice. With the duration of diet,
DC numbers significantly increased in Ldlr2/2 mice (Figure 3).
While the subpopulations of CD11c+ CD103+ and CD11c+
CD11b+ F4/80+ DCs showed the most marked expansion among
all DC subsets, the smaller population of CD11c+ CD11b+ F4/
802 DCs showed a less dramatic increase. CD11c+ CD11b2 F4/
Figure 3. Quantification of aortic DC subsets. Aortic DC and macrophage numbers were quantified in the aorta of C57BL/6J and Ldlr2/2 mice
fed a normal chow, or in Ldlr2/2 mice after 6 or 12 weeks of high fat diet-feeding by flow cytometry (n = 6–9 mice per group; data were obtained by
pooling 2–3 aortae per experiment and then calculating the average number of cells per mouse and aorta, and represent 6–9 independent
experiments). Data represent mean6SEM. *P,0.05.
doi:10.1371/journal.pone.0088452.g003
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802 DCs did not contribute to the increase in DC numbers with
diet. Analysis of the frequencies of distinct DCs subsets among all
DCs showed a slight but non-significant expansion of CD11c+
CD103+ DCs, whereas relative numbers of CD11c+ CD11b+ F4/
802 DCs decreased in Ldlr2/2 mice fed a HFD for 12 weeks
compared to C57BL/6 mice; percentages among all other DC
subsets showed no alterations in the course of atherosclerotic lesion
development (Figure S2).
To further validate data obtained by flow cytometry, co-
immunofluorescence staining for CD11c and F4/80, as well as
CD11c and CD68 were performed in sections of the aortic root of
Ldlr2/2 mice fed a HFD for 12 weeks. As expected, we were able
to identify cells positive for CD11c or F4/80 only, but also double
positive CD11c+ F4/80+ cells, in line with the presence of CD11c+
F4/80+ and CD11c+F4/802 DCs, as well as CD11c2 F4/80+
macrophages, furthermore supporting our findings from flow
cytometry (Figure 4). Similar results were obtained for CD11c
and CD68 (Figure S3). In line with published data that also
CD11c+ cells can take on a foam cell-like appearance upon the
engulfment of lipids similar to macrophages [6,7], no clear further
discrimination into different cell populations was possible based on
staining for lipids by Oil-red-O.
Characterization of Aortic DC Subsets
The signal-regulatory protein (Sirp)-a, a transmembrane
receptor with functions in cell migration and phagocytosis, was
recently described to be expressed on CD11b+ DCs and
monocytes/macrophages [11,19–21]. Its expression had not been
investigated in aortic macrophages and DCs. We here demon-
strate that CD11c+CD11b+F4/802 and CD11c+CD11b+F4/80+
DCs express SIRPa, similarly to CD11c2 MHCII+ F4/80+
macrophages, whereas CD11c+CD11b2 F4/802 DCs display
intermediate levels; CD11c+CD103+ DCs do not express SIRPa
(Figure 5). No differences in SIRPa expression were noted
between chow-fed C57BL/6 and Ldlr2/2 mice or HFD-fed Ldlr2/
2 mice (not shown, and Figure 5).
The discrimination of monocytes/macrophages from DCs
remains controversial. In the aorta, Choi et al. distinguished these
cell types by functional criteria, i.e. phagocytic versus immune
stimulatory capacities [10]. Moreover, CD11c2 F4/80+ CD11b+
macrophages were shown to depend on hematopoietin M-CSF, in
line with a monocytic origin, whereas DCs were of two types, with
CD11b+ F4/80+ DCs being M-CSF but CD103+ DCs being FMS-
like tyrosine kinase 3 (Flt3)-dependent, as revealed by analysing
op/op and Flt32/2 mice on normal chow, respectively [10]. We
analyzed aortic DC distributions in Flt3l2/2 mice. Similar to
findings in Flt32/2 mice [10], we observed a trend towards
reduced total CD11c+MHCII+ DC counts in Flt3l2/2 compared
to C57BL/6 mice (9996287 vs. 18276137 cells per aorta,
respectively; n = 3 independent experiments; n.s) but no changes
in CD11c2CD11b+F4/80+ macrophages (2929.0.26763.1 vs.
3517.06605.3 cell, n.s). The analysis of individual DC populations
Figure 4. Characterization of aortic DC subsets. Representative co-immunofluorescence staining of aortic root sections of Ldlr2/2 mice fed a
high fat diet for 12 weeks, revealing cells showing staining for only CD11c (red, filled arrow heads) or F4/80+ (green, narrow arrows) as well as both
CD11c and F4/80 (yellow, bold arrows). Nuclei are counterstained with DAPI (blue). Oil-red-O staining (red) for lipids in adjacent sections. Scale bars,
50 mm.
doi:10.1371/journal.pone.0088452.g004
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revealed no alterations in CD11c+CD11b+F4/80+ DCs
(512.26143.2 vs. 797.2663.1 cells, n.s.) and CD11c+CD11b2
F4/802 DCs (382.3695.9 vs. 377.3636.8 cells, n.s.) in Flt3l2/2
compared to C57BL/6 mice. Similar to Flt32/2 mice, we
evidenced a complete absence of CD11c+CD103+ DCs in
Flt3l2/2 compared to C57BL/6 mice. Notably, we in addition
evidenced an almost complete loss of CD11c+CD11b+ F4/802
DCs in Flt3l2/2 mice (Figure S4). These findings demonstrate
that not only aortic CD103+ DCs but also CD11c+CD11b+ F4/
802 DCs depend on Flt3/Flt3L signaling under physiological
conditions, whereas CD11c+CD11b+F4/80+ and CD11b2F4/802
DCs, similar to macrophages, accumulate Flt3L-independently in
the aorta in healthy mice.
Recent gene-expression studies (Immunological Genome pro-
ject) have revealed the high-affinity Fcc-receptor-I CD64 as a
promising marker to distinguish macrophages from CD11b2 DCs
[22]. Furthermore, CD64 was shown to be expressed on
monocyte-derived DCs but not conventional DCs [23,24]. We
therefore tested the expression of CD64 on macrophages and on
the identified distinct DC subsets. While CD11c2 CD11b+ F4/80+
macrophages showed uniform staining for CD64 (serving as a
positive control), none of the CD11c+ MHCII+ DC subsets
displayed any surface expression of CD64 in C57BL/6 or Ldlr2/2
mice on normal chow (not shown, Figure 6). These findings could
suggest that aortic CD11c+ subsets are conventional DCs rather
than monocyte-derived DCs under physiological conditions. In
contrast, when analyzing atherosclerotic Ldlr2/2 mice fed a HFD
for 12 weeks, a small fraction of CD11c+ CD11b+ F4/802 DCs,
and about half of all CD11c+ CD11b+ F4/80+ DCs stained
positive for CD64, while CD11c+ CD11b2 F4/802 DCs and
CD11c+ CD103+ DCs remained negative (Figure 6). Among all
DCs, about 21% of cells stained positive for CD64 under
atherogenic conditions (not shown). All macrophages remained
CD64+ also in atherosclerotic mice (Figure 6). These data suggest
that predominantly CD11c+ CD11b+ F4/80+ aortic DC subsets
may be of monocytic origin in atherosclerosis.
Discussion
Extending previous studies [6,10,16] we here further refine the
characterization of DCs in the aorta. After segregation of CD11c2
MHCII+ cells, denominated as macrophages [10,12,13], we
further discriminated CD11c+ MHCII+ ‘DCs’ into a distinct
CD103+ population, and CD1032 DCs that could further be
subdivided into CD11b2 F4/80+ and CD11b+ F4/80+ DCs,
similar to DC populations defined by gating strategies proposed by
others [6,10]. In addition we here were able describe a CD11b2
F4/802 DC population. While it was demonstrated that all
CD11b2 F4/802 DCs express CD103 [10], we identified two
distinct CD11b2 F4/802 DC subsets, namely CD11b2 F4/802
CD103+ DCs (as previously described by Choi et al.), but also
CD11b2 F4/802 CD1032 DCs. Koltsova et al. have previously
referred to a subset of CD11c+CD11b2 DCs in the aorta, which
may have overlapped with both CD11b2F4/802 CD103+ and
CD11b2F4/802 CD1032 DCs [6]. These aortic DCs were
present in healthy and diseased aortae (independent of athero-
sclerotic lesion formation). While we excluded staining for CD3,
CD19, CD103, NK1.1, F4/80, CD11b and CD64, this CD11c+
MHCII+ DC subset remains to be characterized in more detail in
future studies.
In line with its expression on monocytes/macrophages and
CD11b+ DCs [11,19,20], we here for the time revealed SIRPa
expression primarily on aortic macrophages, CD11b+ F4/80+ and
CD11b+ F4/802 DCs, whereas the newly identified subset of
CD11b2 F4/802 CD1032 DCs showed partial staining for
SIRPa.
Consistent with previous findings, substantially more macro-
phages than DCs could be detected in non-diseased, healthy
vessels, which may primarily localize to the adventitia. In contrast,
DCs have been ascribed to accumulate in the intima and in
regions predisposed to atherosclerosis in non-diseased mice
[3,4,10]. Although it was suggested that intimal DCs may originate
from circulating monocytes [4], previous studies lacked DC subset-
specific analyses, and global gene expression analyses, for example
from intimal regions, demonstrated expression of DC and
macrophage markers [4]. Choi et al. showed that the subset of
CD11b+ F4/80+ DCs (but not CD11b+ F4/802 DCs), similarly to
macrophages, strongly depends on M-CSF and expresses
CX3CR1 and CD14 in healthy mice, consistent with a potential
monocytic origin. In contrast, only CD103+ DCs were identified as
true DCs requiring Flt3 for their accumulation in the aorta [10].
None of the CD11c+ MHCII+ DCs displayed any surface
expression of CD64 in healthy mice, postulated as a potentially
powerful marker to distinguish macrophages from DCs [22] and
Figure 5. SIRPa expression on aortic DC subsets and macrophages. Representative histograms of the expression of SIRPa on DC subsets and
macrophages in the aorta of Ldlr2/2 mice fed a normal chow or after 12 weeks of high fat diet-feeding. Representative histograms from 6–9 mice per
group are shown.
doi:10.1371/journal.pone.0088452.g005
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to differentiate monocyte-derived DCs from conventional
(CD11b+) DCs [23]. Moreover, both CD11c+ CD103+ DCs and
CD11c+ CD1032 CD11b+ F4/802 DCs were Flt3L-dependend
and lacked surface expression of CD64. This would suggest not
only aortic CD103+ [10] but also CD1032 CD11b+ F4/802 DCs
to belong to conventional rather than monocyte-derived DCs and
to differentiate from a designated DC precursor in the aorta under
physiological conditions. This would also be supported by
published data that show a reduction in both CD103+ and
CD11b+ DCs in Flt3 and Flt3l-deficient mice in other nonlym-
phoid tissue [25,26], in accordance with a role of Flt3L in driving
the differentiation of progenitor cells (but not monocytes) to the
DC lineage [27] and Flt3-dependent common DC precursors
(CDPs) and pre-DCs to give rise to both CD103+ and CD11b+
cDCs in the liver and kidney [25]. Likewise,CD642/loCD11b+
DCs were recently shown to develop in a Flt3L-dependent manner
under steady state conditions in the skin [24]. CD11c2 macro-
phages and CD11b+ F4/80+ DCs were unaffected by the
deficiency of Flt3L in our experiments under physiological
conditions. The exact differentiation pathways of DCs, in
particular of CD11c+ CD11b+F4/80+ and CD11c+
CD1032CD11b2F4/802 DCs, in the aorta in healthy mice,
however, remain to be defined.
Notably, in the skin CD64lo/+ CD11b+ DCs were shown to
develop from circulating Ly-6Chi monocytes and to display low to
intermediate levels of CD64 [24], which may similarly apply to
monocyte-derived DCs in the aorta in mice. The emergence of
CD64lo/+ CD11b+ F4/802 and CD11b+ F4/80+ DCs in the aorta
in atherosclerosis may thus indicate that these subsets are in part
derived from immigrated monocytes during atherosclerotic lesion
formation. Although it may be possible that the marker CD64
does not assist in defining the origin of aortic DCs, we can rule out
that lack of CD64 staining was due to technical problems, given
the uniform staining of CD64 in macrophages in all experiments.
Notably, higher numbers of CD11c+ DCs than CD11c2
macrophages [10] were observed in advanced atherosclerotic
plaques. Given that CD11c+MHCII+CD11b+ F4/80+ DCs
represent the largest DC subpopulation, and that macrophages
can express CD11c under inflammatory conditions [6,28], it
remains to be defined whether this discrimination into DCs versus
macrophages in the aorta, based on the expression of CD11c,
holds true in future studies, in particular, as these cell subsets share
similar expression of F4/80 and CD11b. Together with a foam
cell-like appearance of CD11c+ cells in the intima upon the
initiation of a HFD [6,7] and in atherosclerotic lesions of CD11c-
YFP apoE2/2 reporter mice in our study, a further functional
characterization of the capacity of aortic CD11c+ and CD11c2
cells and of individual DC subsets (with regards to migration,
phagocytosis and immune priming) is clearly warranted not only in
healthy mice [10], but also under conditions of HFD to resolve this
question. Unambiguous surface markers to discriminate these cell
populations remain to be defined. Moreover, a decision on
whether the gated DC populations represent true lineage subsets
(as seen for CD4+ and CD8+ T cells), display different
transcriptionally active states (as in Th1, Th2 and Tregs), or
whether DC subsets just up- or down-regulate these surface
markers (as also known for T cells or for macrophages during M1/
M2 polarization) remains to be determined.
Our data enhance our knowledge about the presence of distinct
DC subsets and their accumulation in atherosclerosis. The
systematic survey of the phenotype and possible origin of aortic
DCs are prerequisites for future studies aiming at defining specific
DC-based therapeutic strategies for the treatment of chronic
vascular inflammation.
Supporting Information
Figure S1 Localization of CD11c+ cells in different
vascular beds. Representative sections of the innominate artery
and the aortic arch of atherosclerotic CD11c-YFP ApoE2/2
reporter mice (arrow heads indicate CD11c+ cells, green). Nuclei
are counterstained with DAPI (blue; scale bars, 50 mm).
(PDF)
Figure S2 Aortic DC subset distribution. DC subsets as
percentages of total DCs in the aorta of Bl6 and Ldlr2/2mice fed a
normal chow, or in Ldlr2/2 mice after 6 or 12 weeks of high fat
diet-feeding (6–9 mice per group). Data represent mean6SEM.
*p,0.05.
(PDF)
Figure S3 Characterization of aortic DC subsets. Rep-
resentative co-immunofluorescence staining of aortic root sections
of Ldlr2/2 mice fed a high fat diet for 12 weeks, revealing cells
showing staining for only CD11c (red, filled arrow heads) or
CD68+ (green, narrow arrows) as well as both CD11c and CD68
(yellow, bold arrows). Nuclei are counterstained with DAPI (blue).
Oil-red-O staining (red) for lipids in adjacent sections. Scale bars,
50 mm.
(PDF)
Figure 6. CD64 expression on aortic DC subsets and macrophages. Representative histograms of CD64 expression on aortic DC subsets and
macrophages. Representative histograms from 6–9 mice per group are shown.
doi:10.1371/journal.pone.0088452.g006
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Figure S4 DCs in the Flt3L-deficient mice. Representative
FACS plots for identification of DC subsets in healthy Flt3l+/+ and
Flt3l2/2 mice, fed a normal chow. After exclusion of TCRb+/
CD19+ T and B cells, macrophages were defined as CD11c2
MHCII+ CD11b+ F4/80+ (left panel), and CD11c+ MHCII+ DCs
were further subdivided into CD103+ and CD1032 DCs (middle
panel). CD1032 DCs were further subdivided into CD11b+ F4/
802, CD11b+ F4/80+ and CD11b2F4/802 DCs (right panel).
(PDF)
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